Opioids Drugs Market Report

Europe Opioids Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 19, 2019
  • PAGES：157
  • REPORT CODE：GMM385781
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Opioids Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Opioids Drugs Market Segmentations:

    By Player:

    • AbbVie

    • Pfizer

    • Allergan

    • Sanofi-aventis US LLC

    • Johnson & Johnson

    • Teva pharmaceuticals

    • Orexo Pharmaceuticals

    • Hospira

    • Endo Pharmaceuticals

    • Purdue Pharma

    By Type:

    • Oxycodone (e.g., OxyContin, Percocet)

    • Hydrocodone (e.g., Vicodin)

    • Codeine

    • Morphine (e.g., Kadian, Avinza)

    • Others

    By End-User:

    • Neuropathic pain treatment

    • Orthopedic pain treatment

    • Other pain treatment

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioids Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Opioids Drugs Market Size and Growth Rate of Oxycodone (e.g., OxyContin, Percocet) from 2014 to 2026

    • 1.3.2 Europe Opioids Drugs Market Size and Growth Rate of Hydrocodone (e.g., Vicodin) from 2014 to 2026

    • 1.3.3 Europe Opioids Drugs Market Size and Growth Rate of Codeine from 2014 to 2026

    • 1.3.4 Europe Opioids Drugs Market Size and Growth Rate of Morphine (e.g., Kadian, Avinza) from 2014 to 2026

    • 1.3.5 Europe Opioids Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Opioids Drugs Market Size and Growth Rate of Neuropathic pain treatment from 2014 to 2026

    • 1.4.2 Europe Opioids Drugs Market Size and Growth Rate of Orthopedic pain treatment from 2014 to 2026

    • 1.4.3 Europe Opioids Drugs Market Size and Growth Rate of Other pain treatment from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioids Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioids Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Oxycodone (e.g., OxyContin, Percocet)

      • 3.4.2 Market Size and Growth Rate of Hydrocodone (e.g., Vicodin)

      • 3.4.3 Market Size and Growth Rate of Codeine

      • 3.4.4 Market Size and Growth Rate of Morphine (e.g., Kadian, Avinza)

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Opioids Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioids Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioids Drugs for Neuropathic pain treatment

      • 4.4.2 Market Size and Growth Rate of Opioids Drugs for Orthopedic pain treatment

      • 4.4.3 Market Size and Growth Rate of Opioids Drugs for Other pain treatment

    5 Market Analysis by Major Regions

    • 5.1 Europe Opioids Drugs Production Analysis by Top Regions

    • 5.2 Europe Opioids Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Opioids Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Opioids Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Opioids Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Opioids Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Opioids Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Opioids Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Opioids Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Opioids Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Opioids Drugs Landscape Analysis

    • 7.1 Germany Opioids Drugs Landscape Analysis by Major Types

    • 7.2 Germany Opioids Drugs Landscape Analysis by Major End-Users

    8. UK Opioids Drugs Landscape Analysis

    • 8.1 UK Opioids Drugs Landscape Analysis by Major Types

    • 8.2 UK Opioids Drugs Landscape Analysis by Major End-Users

    9. France Opioids Drugs Landscape Analysis

    • 9.1 France Opioids Drugs Landscape Analysis by Major Types

    • 9.2 France Opioids Drugs Landscape Analysis by Major End-Users

    10. Italy Opioids Drugs Landscape Analysis

    • 10.1 Italy Opioids Drugs Landscape Analysis by Major Types

    • 10.2 Italy Opioids Drugs Landscape Analysis by Major End-Users

    11. Spain Opioids Drugs Landscape Analysis

    • 11.1 Spain Opioids Drugs Landscape Analysis by Major Types

    • 11.2 Spain Opioids Drugs Landscape Analysis by Major End-Users

    12. Poland Opioids Drugs Landscape Analysis

    • 12.1 Poland Opioids Drugs Landscape Analysis by Major Types

    • 12.2 Poland Opioids Drugs Landscape Analysis by Major End-Users

    13. Russia Opioids Drugs Landscape Analysis

    • 13.1 Russia Opioids Drugs Landscape Analysis by Major Types

    • 13.2 Russia Opioids Drugs Landscape Analysis by Major End-Users

    14. Switzerland Opioids Drugs Landscape Analysis

    • 14.1 Switzerland Opioids Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Opioids Drugs Landscape Analysis by Major End-Users

    15. Turkey Opioids Drugs Landscape Analysis

    • 15.1 Turkey Opioids Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Opioids Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Opioids Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Opioids Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Opioids Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Opioids Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Opioids Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Opioids Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Opioids Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Opioids Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Opioids Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Opioids Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Opioids Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 AbbVie

      • 19.1.1 AbbVie Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Pfizer

      • 19.2.1 Pfizer Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Allergan

      • 19.3.1 Allergan Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sanofi-aventis US LLC

      • 19.4.1 Sanofi-aventis US LLC Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Johnson & Johnson

      • 19.5.1 Johnson & Johnson Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Teva pharmaceuticals

      • 19.6.1 Teva pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Orexo Pharmaceuticals

      • 19.7.1 Orexo Pharmaceuticals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Hospira

      • 19.8.1 Hospira Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Endo Pharmaceuticals

      • 19.9.1 Endo Pharmaceuticals Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Purdue Pharma

      • 19.10.1 Purdue Pharma Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 76 Figures and 120 Tables)

    • Figure Product Picture

    • Figure Europe Opioids Drugs Market Size and Growth Rate of Oxycodone (e.g., OxyContin, Percocet) from 2014 to 2026

    • Figure Europe Opioids Drugs Market Size and Growth Rate of Hydrocodone (e.g., Vicodin) from 2014 to 2026

    • Figure Europe Opioids Drugs Market Size and Growth Rate of Codeine from 2014 to 2026

    • Figure Europe Opioids Drugs Market Size and Growth Rate of Morphine (e.g., Kadian, Avinza) from 2014 to 2026

    • Figure Europe Opioids Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Opioids Drugs Market Size and Growth Rate of Neuropathic pain treatment from 2014 to 2026

    • Figure Europe Opioids Drugs Market Size and Growth Rate of Orthopedic pain treatment from 2014 to 2026

    • Figure Europe Opioids Drugs Market Size and Growth Rate of Other pain treatment from 2014 to 2026

    • Figure Germany Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Opioids Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioids Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioids Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioids Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Opioids Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Oxycodone (e.g., OxyContin, Percocet)

    • Figure Market Size and Growth Rate of Hydrocodone (e.g., Vicodin)

    • Figure Market Size and Growth Rate of Codeine

    • Figure Market Size and Growth Rate of Morphine (e.g., Kadian, Avinza)

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioids Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioids Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Neuropathic pain treatment

    • Figure Market Size and Growth Rate of Orthopedic pain treatment

    • Figure Market Size and Growth Rate of Other pain treatment

    • Table Europe Opioids Drugs Production by Major Regions

    • Table Europe Opioids Drugs Production Share by Major Regions

    • Figure Europe Opioids Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Opioids Drugs Consumption by Major Regions

    • Table Europe Opioids Drugs Consumption Share by Major Regions

    • Table Germany Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table UK Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table France Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Opioids Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Opioids Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Opioids Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Opioids Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Germany Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Opioids Drugs Consumption by Types from 2014 to 2026

    • Table UK Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Opioids Drugs Consumption by Types from 2014 to 2026

    • Table France Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table France Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table France Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Italy Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Spain Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Poland Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Russia Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioids Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioids Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioids Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Opioids Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Sanofi-aventis US LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-aventis US LLC

    • Figure Sales and Growth Rate Analysis of Sanofi-aventis US LLC

    • Figure Revenue and Market Share Analysis of Sanofi-aventis US LLC

    • Table Product and Service Introduction of Sanofi-aventis US LLC

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Teva pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Teva pharmaceuticals

    • Figure Revenue and Market Share Analysis of Teva pharmaceuticals

    • Table Product and Service Introduction of Teva pharmaceuticals

    • Table Company Profile and Development Status of Orexo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Orexo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Orexo Pharmaceuticals

    • Table Product and Service Introduction of Orexo Pharmaceuticals

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Endo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Endo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Endo Pharmaceuticals

    • Table Product and Service Introduction of Endo Pharmaceuticals

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US